CLINICAL_TRIALS
trial_result
· 2023-02-01
Clinical Trial Update: A Study of LY3462817 in Participants With Rheumatoid Arthritis [Phase 2]
Summary
Phase 2 trial update for LY3462817 in rheumatoid arthritis completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2023-02-01